STOCK TITAN

Oxford Square Capital 7.75% Notes due 2030 (OXSQH) Financials

OXSQH NASDAQ
Trailing 12 months to September 30, 2026
Revenue Not reported for the trailing 12 months
Net Income -$32.9M n/m YoY
EPS (Diluted) $0.30 FY2025 annual
Operating Cash Flow -$26.7M n/m YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the OXSQH SEC filings page.

This page shows Oxford Square Capital Corp. 7.75% Notes due 2030 (OXSQH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI OXSQH FY2025

Reported assets edged up in FY2025 while losses and negative operating cash flow made distributions dependent on financing.

Earnings quality changed sharply across the period: FY2023 net income was $17.2M alongside operating cash flow of $65.5M, while FY2025 recorded a net loss of $18.7M and operating cash flow of -$13.7M. The swing from cash generation to cash consumption shows that reported profitability has not translated consistently into operating funds.

The balance sheet became more burdened in FY2025: liabilities reached 52.6% of assets, while liabilities rose 16.0% and equity fell 9.5% from FY2024. That combination points to a financing structure relying more heavily on creditors as the capital base contracts.

FY2025 financing cash flow was $30.7M, while dividends were $31.3M. With operating cash flow negative, the figures indicate that distributions were not funded by that year's operations; financing activity supplied roughly the same scale of cash as the distributions.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Oxford Square Capital Corp. 7.75% Notes due 2030, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Piotroski F-Score Partial
1/5

Oxford Square Capital Corp. 7.75% Notes due 2030 passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality No Cash Backing
N/A

Oxford Square Capital Corp. 7.75% Notes due 2030 reported a net loss of $18.7M while operations used $13.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
$1.6M
YoYn/m
QoQ-60.8%

Oxford Square Capital Corp. 7.75% Notes due 2030 reported $1.6M in net income in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 60.8%.

EPS (Diluted)
$0.04
YoY-42.9%

Oxford Square Capital Corp. 7.75% Notes due 2030 earned $0.04 per diluted share (EPS) in Q3 2026. This represents a decrease of 42.9% from the same quarter a year earlier.

Revenue

Not reported for Q3 2026.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Cash & Debt
$43.5M
YoY-14.3%
QoQ+25.7%

Oxford Square Capital Corp. 7.75% Notes due 2030 held $43.5M in cash as of Q3 2026; no long-term debt figure is on record for that period.

Shares Outstanding
121M
YoY+48.5%

Oxford Square Capital Corp. 7.75% Notes due 2030 had 121M shares outstanding in Q3 2026. This represents an increase of 48.5% from the same quarter a year earlier.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Return on Equity
1.1%
YoY+2.4pp
QoQ-1.9pp

Oxford Square Capital Corp. 7.75% Notes due 2030's quarterly ROE was 1.1% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 2.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.9 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not reported for Q3 2026.

Net Margin

Not reported for Q3 2026.

Capital Allocation

None of these metrics is reported for Q3 2026.

OXSQH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OXSQH quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
RevenueN/AN/AN/AN/AN/AN/A$5.7MN/A
SG&A Expenses$504K+40.9%$359K-0.4%$313K-12.0%N/A$358K-9.5%$360K-19.5%$355K+2.5%N/A
Interest Expense$2.8M+9.3%$2.8M+44.8%$2.8M+42.5%$2.8M$2.6M+30.4%$1.9M-1.6%$2.0M-0.1%N/A
Net Income$1.6Mn/m$4.0M-8.9%-$25.5Mn/m-$12.9M-495.4%-$2.1Mn/m$4.4M-16.6%-$8.1Mn/m$3.3Mn/m
EPS (Basic)$0.04-42.9%$0.05-37.5%$0.05-44.4%N/A$0.07-30.0%$0.08-38.5%$0.09-18.2%$0.09
EPS (Diluted)$0.04-42.9%$0.05-37.5%$0.05-44.4%N/A$0.07-30.0%$0.08-38.5%$0.09-18.2%$0.09
Diluted Shares (Avg)111M+40.2%99M+35.5%88M+26.1%N/A79M+22.5%73M+20.8%70M+17.3%N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Income Tax.

OXSQH Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OXSQH quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$307.1M-2.4%$290.6M+5.7%$278.9M-2.3%$306.7M+2.3%$314.7M+0.6%$274.8M-5.3%$285.5M+3.7%$299.7M+7.9%
Cash & Equivalents$43.5M-14.3%$34.6M+16.2%$40.9M+9.9%$51.9M+48.7%$50.8M+17.6%$29.8M-0.7%$37.3M+78.2%$34.9M+508.4%
Total Liabilities$161.7M+3.8%$155.6M+32.5%$155.6M+13.9%$161.3M+16.0%$155.8M+1.5%$117.4M-14.8%$136.6M+4.3%$139.1M+10.1%
Total Equity$145.4M-8.5%$135.0M-14.2%$123.3M-17.2%$145.4M-9.5%$159.0M-0.3%$157.4M+3.3%$148.9M+3.1%$160.7M+6.2%
Retained Earnings-$430.0Mn/m-$419.8Mn/m-$413.3Mn/m-$378.5Mn/m-$357.2Mn/m-$346.8Mn/m-$343.4Mn/m-$328.0Mn/m

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

OXSQH Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OXSQH quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$116Kn/m-$14.1Mn/m-$14.4M-340.4%$1.7Mn/m-$19.8M-477.4%-$1.7M-126.1%$6.0M-70.5%-$6.2M-162.1%
Financing Cash Flow$8.8M-78.4%$7.8Mn/m$3.4Mn/m-$562Kn/m$40.8M+413.9%-$5.8M-311.6%-$3.7Mn/m-$2.1Mn/m
Dividends Paid$10.6M+30.7%$10.0M+34.1%$8.9M+25.2%$8.6M+22.7%$8.1M+24.1%$7.5M+21.3%$7.1M+17.8%$7.0M+18.3%

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Share Buybacks.

OXSQH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OXSQH quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Net MarginN/AN/AN/AN/AN/AN/A-143.3%N/A
Return on Equity1.1%+2.4pp3.0%+0.2pp-20.7%-15.3pp-8.9%-10.9pp-1.3%-0.8pp2.8%-0.7pp-5.5%-4.2pp2.0%+6.9pp
Return on Assets0.5%+1.2pp1.4%-0.2pp-9.2%-6.3pp-4.2%-5.3pp-0.7%-0.4pp1.6%-0.2pp-2.8%-2.2pp1.1%+3.7pp
Liabilities-to-Equity1.11+0.1x1.15+0.4x1.26+0.3x1.11+0.2x0.980.0x0.75-0.2x0.920.0x0.870.0x
Asset TurnoverN/AN/AN/AN/AN/AN/A0.02N/A

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, Debt-to-Equity, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Frequently Asked Questions

No, Oxford Square Capital Corp. 7.75% Notes due 2030 (OXSQH) reported a net loss of $32.9M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $18.7M.

Oxford Square Capital Corp. 7.75% Notes due 2030 (OXSQH) reported diluted earnings per share of $0.30 for fiscal year 2025. This represents a -28.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Oxford Square Capital Corp. 7.75% Notes due 2030 (OXSQH) has a return on equity of -12.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Oxford Square Capital Corp. 7.75% Notes due 2030 (OXSQH) recorded an outflow of $13.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Oxford Square Capital Corp. 7.75% Notes due 2030 (OXSQH) had $306.7M in total assets as of fiscal year 2025, including both current and long-term assets.

Oxford Square Capital Corp. 7.75% Notes due 2030 (OXSQH) had 88M shares outstanding as of fiscal year 2025.

Oxford Square Capital Corp. 7.75% Notes due 2030 (OXSQH) had a liabilities-to-equity ratio of 1.11 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

Oxford Square Capital Corp. 7.75% Notes due 2030 (OXSQH) had a return on assets of -6.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Oxford Square Capital Corp. 7.75% Notes due 2030 (OXSQH) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Oxford Square Capital Corp. 7.75% Notes due 2030 (OXSQH) reported a net loss of $18.7M while operations used $13.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top